Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people

Benef Microbes. 2017 Feb 7;8(1):23-29. doi: 10.3920/BM2016.0135. Epub 2016 Dec 1.

Abstract

This study investigated relationships between the frequent intake of fermented milk products containing Lactobacillus casei strain Shirota (LcS) and the onset of hypertension (resting systemic pressure ≥140 mmHg [systolic]/≥90 mmHg [diastolic], a doctor's diagnosis and/or antihypertensive medicine use) during a 5-year period in 352 communityliving Japanese aged 65 to 93 years (125 men and 227 women). Initially normotensive subjects were divided into two groups (n=254 and n=98) on the basis of their intake of fermented milk products (<3 or ≥3 times/week, respectively), as estimated during an interview by a certified nutritionist. The incidence of hypertension over the 5-year interval was significantly lower in those who took fermented milk products ≥3 rather than <3 times/week (6.1 vs 14.2%, P=0.037). A multivariate-adjusted proportional hazards model predicted that blood pressures were significantly more likely to remain normal over 5 years in subjects who took ≥3 fermented milk products rather than <3 times/ week (relative risk 0.398 [95% confidence interval 0.167-0.948], P=0.037). These results suggest that after adjustment for potential confounders, the risk of developing hypertension is substantially lower in elderly people who take fermented milk products containing LcS at least 3 times a week.

Keywords: aging; blood pressure; cardiovascular disease; diet; probiotics.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging
  • Animals
  • Antihypertensive Agents / administration & dosage*
  • Blood Pressure
  • Cultured Milk Products / microbiology*
  • Diet
  • Female
  • Fermentation
  • Humans
  • Hypertension / prevention & control*
  • Lactobacillus casei / physiology*
  • Male
  • Probiotics / administration & dosage*

Substances

  • Antihypertensive Agents